Publications
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | Second Faculty of Medicine, First Faculty of Medicine
- Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients2017 | Second Faculty of Medicine
- Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy2016 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Adoptive T cell therapy in cancer treatment +12013 | Second Faculty of Medicine
Loading network view...